Among subjects identified as having dementia by the prediction model, 43.5% to 50.2%, depending on the survey year, reported that they were informed of the dementia status by their physician. 5 key findings →
Design: cohort study
Participants: 8,686
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Generally, Blacks and Latinos reported higher prevalence of poor HRQOL compared with whites. 5 key findings →
Design: cohort study
Participants: 10,886
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
69/100
✓ Peer-reviewed
alzhub usefulness score 69 out of 100.
·
JAMA network open
·
2020-08-03
Black decedents were less likely than White decedents to use hospice for 3 or more days (132 of 378 [34.9%] vs 385 of 834 [46.2%]; P Conclusions and relevance Despite the increase in the use of hospice care in recent decades, racial disparities in the use of hospice remain, especially for noncancer deaths. 1 key finding →
Design: cohort study
Participants: 1,212
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
69/100
✓ Peer-reviewed
alzhub usefulness score 69 out of 100.
·
The Gerontologist
·
2021-07-01
Random-effects models revealed small but statistically significant effects with better psychological well-being in African American caregivers compared with white caregivers in both population-based (d = -0.22) and convenience sample studies (d = -0.21). 2 key findings →
Design: meta-analysis
Participants: 159
Evidence: high
Full summary, score breakdown and related studies →
Original source
Free full text
MCI prevalence varied among Hispanic/Latino backgrounds, but not as widely as reported in the previous studies. 5 key findings →
Design: cohort study
Participants: 6,377
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
69/100
✓ Peer-reviewed
alzhub usefulness score 69 out of 100.
·
JAMA network open
·
2022-06-01
The cohort sample included 5058 beneficiaries with dementia (mean [SD] age, 85.5 [8.0] years; 3038 women [60.1%]; 809 [16.0%] non-Hispanic Black, 357 [7.1%] Hispanic, and 3892 non-Hispanic White respondents [76.9%]). 4 key findings →
Design: cohort study
Participants: 5,058
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
Policies regarding sustained hospice eligibility should account for the variable and protracted end-of-life trajectory of patients with dementia. 3 key findings →
Design: cohort study
Participants: 2,629
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
The available evidence suggests that ethnicity and race may influence blood biomarker concentrations. 3 key findings →
Design: systematic review
Evidence: high
Full summary, score breakdown and related studies →
Original source
This large study followed over 274,000 members of a single California health system for 14 years and found striking differences in dementia rates by race and ethnicity. 5 key findings →
Design: cohort
Participants: 274,283
Evidence: high
Full summary, score breakdown and related studies →
Original source
Over follow-up, 449 (18.3%) participants developed dementia. 2 key findings →
Design: cohort study
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
Where feasible, we combined data to obtain an overall estimate of effect. 4 key findings →
Evidence: high
Full summary, score breakdown and related studies →
Original source
Free full text
Socioeconomic factors and genetic predisposition are established risk factors for dementia. 4 key findings →
Design: cohort study
Participants: 196,368
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
AADAPt participants had risk factors for developing dementia in future, such as hypertension and hyperlipidemia, but also reported protective factors such as high social engagement. 2 key findings →
Design: longitudinal study
Participants: 177
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
A total of 243 participants were enrolled, 81 of which had a recent ischemic stroke. 5 key findings →
Design: case-control study
Participants: 243
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
67/100
✓ Peer-reviewed
alzhub usefulness score 67 out of 100.
·
JAMA neurology
·
2019-03-01
There were no racial differences in the frequency of cerebral ischemic lesions noted on results of brain magnetic resonance imaging, mean cortical standardized uptake value ratios for Pittsburgh compound B, or for amyloid-β42 concentrations in CSF. 4 key findings →
Design: cross-sectional
Participants: 1,255
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
In patients with sporadic ALS, we identified the repeat expansion in 236 (7·0%) of 3377 white individuals from the USA, Europe, and Australia, two (4·1%) of 49 black individuals from the USA, and six (8·3%) of 72 Hispanic individuals from the USA. 1 key finding →
Participants: 4,448
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
The number of people with dementia from minority ethnic (ME) groups in western countries is projected to rise dramatically, and they may be less able to access dementia services. 1 key finding →
Design: systematic review
Participants: 2,090
Evidence: high
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
67/100
✓ Peer-reviewed
alzhub usefulness score 67 out of 100.
·
Medical care
·
2021-08-01
When diagnosed, non-Hispanic Blacks and Hispanics may have more advanced dementia. 1 key finding →
Design: cohort study
Participants: 3,966
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
67/100
✓ Peer-reviewed
alzhub usefulness score 67 out of 100.
·
JAMA neurology
·
2020-12-01
Of the 7342 total sample, 4348 participants (60.3%) were women. 5 key findings →
Design: cohort study
Participants: 7,342
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
67/100
✓ Peer-reviewed
alzhub usefulness score 67 out of 100.
·
EClinicalMedicine
·
2021-07-23
People who had recovered from COVID-19, including those no longer reporting symptoms, exhibited significant cognitive deficits versus controls when controlling for age, gender, education level, income, racial-ethnic group, pre-existing medical disorders, tiredness, depression and anxiety. 2 key findings →
Design: cross-sectional
Participants: 192
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
TREM2 encodes for triggering receptor expressed on myeloid cells 2 and has rare, coding variants that associate with risk for late-onset Alzheimer's disease (LOAD) in Caucasians of European and North-American origin. 4 key findings →
Design: case-control study
Participants: 800
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
67/100
✓ Peer-reviewed
alzhub usefulness score 67 out of 100.
·
JAMA network open
·
2019-12-02
Data from 362 study participants were analyzed (mean [SD] age, 65.6 [7.9] years), of whom 152 (42.0%) were African American, 230 (63.5%) were women, and 189 (52.2%) had MCI. 4 key findings →
Design: case-control study
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
67/100
✓ Peer-reviewed
alzhub usefulness score 67 out of 100.
·
JAMA network open
·
2021-07-01
Racial/ethnic groups differed in sources of recruitment, reasons for screen failure, and overall probability of eligibility in a preclinical AD trial. 5 key findings →
Design: cross-sectional
Participants: 5,945
Evidence: low
Full summary, score breakdown and related studies →
Original source
Dual-eligible older persons are at greater risk for decline in function and cognition after an ICU hospitalization than their more advantaged counterparts. 2 key findings →
Design: cohort study
Participants: 641
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
67/100
✓ Peer-reviewed
alzhub usefulness score 67 out of 100.
·
BMJ open
·
2023-11-10
Increased cardiovascular risk as evidenced by FRS was associated with poorer cognitive performance in all cognitive domains among dementia-free middle-aged and older rural Indians. 3 key findings →
Design: cross-sectional
Participants: 3,609
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
How the 0–100 score works — and why some entries are capped
This is alzhub's own score. It is not an official metric, not an impact factor,
and no journal, publisher or ranking body endorses it. We built it so that a reader who is not a
scientist can tell a landmark trial from a conference abstract without having to already know the
difference. Every point comes from one of 20 components, all of them printed on the study itself,
so you can disagree with our arithmetic rather than having to trust the total.
- Journal tier up to 10 pts
- Journal's citation record up to 4 pts
- Study design up to 12 pts
- Strength of evidence up to 5 pts
- Peer-review validation up to 10 pts
- How recent up to 5 pts
- Sample size up to 4 pts
- Effect reported up to 3 pts
- Studied in people up to 3 pts
- Randomized / blinded up to 2 pts
- Times cited up to 7 pts
- Citations per year up to 5 pts
- Impact for its field and year up to 6 pts
- Cited by studies here up to 6 pts
- Still being cited up to 4 pts
- Senior author's track record up to 4 pts
- Institution's track record up to 3 pts
- Multicenter collaboration up to 3 pts
- Indexed in PubMed up to 2 pts
- Free to read up to 2 pts
Journals are placed in ordered tiers, never given a numeric impact factor — we
could not verify current impact factors from a source we control, and an invented one would be
worse than none. Tier 1 is the top-tier general journals (NEJM, The Lancet, JAMA, Nature, Science,
Nature Medicine); tier 2 is the leading specialty journals; tier 3 is every other peer-reviewed
journal. A separate part scores how much the journal's own papers are cited, which tells the
tier-3 journals apart.
Two rules we don't bend. First, we never fill in a
missing value: if a record does not state a sample size or a design, that component scores
zero, and if we simply have no data for a part, such as a citation count, that part is left out and
the study is scored on the parts we could check. The study card says which. Second, anything that is not a peer-reviewed
article is capped at 16/100 and carries a warning chip — so a conference abstract or
a company press release can never outrank a peer-reviewed paper, no matter how good it looks.
We rank a rigorous null result — a good trial showing that something does not
work — above an early positive finding. Someone deciding whether to buy a supplement is served by
that, and the rigour is already counted by the design and journal components.
The score is computed from the published data alone and is
reproducible: the same file always yields the same numbers.
See the whole rubric drawn out →
— four charts covering all 33,780 studies: how the scores are spread and where the cap
bites, which of the 20 components the library is strong and weak on, which subjects rest on
stronger evidence, and what kinds of study each subject is actually built from.